Westlake Chemical (NYSE:WLKP) Azioni

Westlake Chemical

Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.

Dividend,Growth,And,Profits,With,Finger,Pointing,On,The,Graph.

Personal Finance

TSLA

TSLP

WLKP

XPAY

Un investitore di 62 anni racconta la sua strategia per l&#39;indipendenza finanziaria. I consigli e i titoli che generano rendita.

Vivere di dividendi nel 2025? Un &#34;redditor&#34; svela come ci riesce

Westlake Chemical Partners LP Common Units representing limited partner interests

Westlake Chemical Partners LP

Dividend investing is gaining traction in 2025 as tariffs and macroeconomic uncertainties continue to weigh on market sentiment. Research from <a href="https://www.spglobal.com/spdji/en/documents/research/research-sp500-dividend-aristocrats.pdf">S&amp;P Global </a>shows that dividend stocks with a strong history of growth have historically delivered higher returns with lower volatility compared to the S&amp;P 500.
Last month, someone <a href="https://www.reddit.com/r/dividends/comments/1ksb79m/anyone_already_living_the_dream_and_living_off/">asked</a> investors on r/Dividends — a Reddit community with over 730,000 followers — whether anyone was living off dividend income. The question drew an overwhelming response, with many investors sharing their advice and experience.&nbsp;
Don't Miss:
<ul class="wp-block-list">
<li>Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>. </li>
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
</ul>
An investor said that he was living off dividends from a diversified portfolio of stocks and funds. He advised Redditors to first pay off all debts and avoid being a "slave" to banks.
&nbsp;"Life is great and we are blessed with dividends!" he wrote. "Invest in quality dividend stocks in all sectors and don&#8217;t waste money on material things you don&#8217;t need but enjoy life!"
The investor, 62, said in a separate comment that he and his wife are retired and their portfolio includes a lot of "qualified" dividend stocks with an average yield of 9%.
"Retired and enjoying dividends without depleting my initial investment. I am diversified across all sectors," he said.
Trending: Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.
Let's take a look at some of the top dividend stocks and funds in his portfolio.
Energy Transfer LP Unit
Energy Transfer LP Unit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ET#NYSE">ET</a>) was among the top high-yield energy dividend stocks in the Redditor's portfolio. The Texas-based company has a dividend yield of about 7.4%. The stock is down 12% so far this year.
Enterprise Products Partners&nbsp;
Texas-based Enterprise Products Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPD#NYSE">EPD</a>) is a midstream energy company with a dividend yield of about 6.8%. The stock recently fell after the company <a href="https://seekingalpha.com/news/4453939-enterprise-products-slips-as-license-requirement-could-lead-to-lower-china-exports">warned</a> that its ethane and butane exports could be impacted due to a new US government licensing requirement for exports to China.
Dow Inc.
Chemicals giant Dow Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOW#NYSE">DOW</a>) was among the top holdings of the investor living off dividends. The stock has a dividend yield of about 10%. In April, Bank of America <a href="https://seekingalpha.com/news/4431475-dow-downgraded-2-levels-by-bank-of-america-amid-risk-to-dividend">downgraded </a>the stock to Underperform from Buy, citing weakening global demand, rising trade barriers and elevated feedstock costs. The stock has lost about 29% so far this year.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Westlake Chemical Partners
Westlake Chemical Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is a Texas-based chemicals company with a dividend yield of about 8.5%. In the fiscal first quarter, the company's net income <a href="https://investors.westlake.com/news/news-details/2025/Westlake-Chemical-Partners-LP-Announces-First-Quarter-2025-Results/default.aspx">fell</a> by $10 million amid lower production and sales volume and higher maintenance capital expenditures.
Kurv Yield Premium Strategy Tesla ETF
The Kurv Yield Premium Strategy Tesla ETF (CBOE: TSLP) provides investors with monthly payouts and exposure to Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) shares. The fund has a distribution rate of about 34%. TSLP is down 22% so far this year.
Roundhill S&amp;P 500 Target 20 Managed Distribution ETF
The Roundhill S&amp;P 500 Target 20 Managed Distribution ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPAY#NYSE">XPAY</a>) pays a return at an annualized rate of 20% and provides investors exposure to the S&amp;P 500.
Read Next: Can you guess how many retire with a $5,000,000 nest egg? <a href="https://www.benzinga.com/money/5mil-nest-egg-adv">The percentage may shock you</a>.
Image: Shutterstock

62-Year-Old Living Off Dividends Shares His Top 6 Stock Picks, Says His 'Life Is Great, Blessed With Dividends'

James Chao, Senior Chairman at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), reported an insider sell on May 30, according to a new SEC filing. 
What Happened: Chao's recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017025079347//Archives/edgar/data/1604665/000095017025079347/0000950170-25-079347-index.htm">U.S. Securities and Exchange Commission</a> on Friday unveiled the sale of 3,700 shares of Westlake Chemical. The total transaction value is $81,770.
Monitoring the market, Westlake Chemical's shares up by 0.05% at $22.06 during Friday's morning.
<h3>Unveiling the Story Behind Westlake Chemical</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develops ethylene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Financial Insights: Westlake Chemical</h3>
Decline in Revenue: Over the 3 months period, Westlake Chemical faced challenges, resulting in a decline of approximately -16.53% in revenue growth as of 31 March, 2025. This signifies a reduction in the company's top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Materials sector.
Profitability Metrics: Unlocking Value
<ul>
<li>
Gross Margin: The company sets a benchmark with a high gross margin of 22.76%, reflecting superior cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Westlake Chemical's EPS is below the industry average. The company faced challenges with a current EPS of 0.14. This suggests a potential decline in earnings.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.51, Westlake Chemical faces challenges in effectively managing its debt levels, indicating potential financial strain.
Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The Price to Earnings ratio of 14.8 is lower than the industry average, indicating potential undervaluation for the stock.
</li>
<li>
Price to Sales (P/S) Ratio: The Price to Sales ratio is 0.71, which is lower than the industry average. This suggests a possible undervaluation based on sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a lower-than-industry-average EV/EBITDA ratio of 2.46, Westlake Chemical presents a potential value opportunity, as investors are paying less for each unit of EBITDA.
</li>
</ul>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Why Insider Activity Matters in Finance</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
When discussing legal matters, the term "insider" refers to any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, as stipulated in Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and significant hedge funds. Such insiders are required to report their transactions through a Form 4 filing, which must be completed within two business days of the transaction.
A new purchase by a company insider is a indication that they anticipate the stock will rise.
On the other hand, insider sells may not necessarily indicate a bearish view and can be motivated by various factors.
<h3>Transaction Codes Worth Your Attention</h3>
Navigating through the landscape of transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often prioritize those unfolding in the open market, precisely detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
Insider Buying Alert: Profit from C-Suite Moves
Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22in8&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here for access</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Insider Trades

Trading Ideas

James Chao Takes Money Off The Table, Sells $81K In Westlake Chemical Stock

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.38 by 63.16 percent. This is a 66.67 percent decrease over earnings of $0.42 per share from the same period last year. The company reported quarterly sales of $237.63 million which missed the analyst consensus estimate of $296.00 million by 19.72 percent. This is a 16.53 percent decrease over sales of $284.67 million the same period last year.

Earnings

Earnings Misses

Westlake Chemical Q1 EPS $0.14 Misses $0.38 Estimate, Sales $237.63M Miss $296.00M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Franklin Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEN#NYSE">BEN</a>) is estimated to report quarterly earnings at $0.47 per share on revenue of $1.98 billion. 
• Arbor Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABR#NYSE">ABR</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $79.89 million. 
• American Axle &amp; Mfg Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AXL#NYSE">AXL</a>) is expected to report quarterly earnings at $0.06 per share on revenue of $1.43 billion. 
• Liberty Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LBTYA#NASDAQ">LBTYA</a>) is expected to report quarterly loss at $0.83 per share on revenue of $1.08 billion. 
• Madison Square Garden (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSGS#NYSE">MSGS</a>) is expected to report quarterly earnings at $1.30 per share on revenue of $427.39 million. 
• United States Cellular (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USM#NYSE">USM</a>) is estimated to report quarterly earnings at $0.37 per share on revenue of $925.42 million. 
• Telephone and Data Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TDS#NYSE">TDS</a>) is likely to report quarterly loss at $0.02 per share on revenue of $1.19 billion. 
• FuboTV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUBO#NYSE">FUBO</a>) is likely to report quarterly loss at $0.03 per share on revenue of $415.45 million. 
• Terex (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEX#NYSE">TEX</a>) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.25 billion. 
• WisdomTree (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WT#NYSE">WT</a>) is projected to report quarterly earnings at $0.15 per share on revenue of $108.98 million. 
• Criteo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRTO#NASDAQ">CRTO</a>) is likely to report quarterly earnings at $0.77 per share on revenue of $260.12 million. 
• Wendy's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WEN#NASDAQ">WEN</a>) is likely to report quarterly earnings at $0.20 per share on revenue of $526.63 million. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEP#NYSE">BEP</a>) is estimated to report quarterly loss at $0.40 per share on revenue of $1.70 billion. 
• Brookfield Renewable (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BEPC#NYSE">BEPC</a>) is likely to report quarterly loss at $0.25 per share on revenue of $2.16 billion. 
• SES AI (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SES#NYSE">SES</a>) is likely to report quarterly earnings at $0.26 per share on revenue of $351.00 million. 
• Fulgent Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGT#NASDAQ">FLGT</a>) is projected to report quarterly loss at $0.18 per share on revenue of $71.26 million. 
• Perella Weinberg (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWP#NASDAQ">PWP</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $205.52 million. 
• Fluor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLR#NYSE">FLR</a>) is likely to report quarterly earnings at $0.50 per share on revenue of $4.18 billion. 
• Brookfield Bus Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBU#NYSE">BBU</a>) is expected to report earnings for its first quarter. 
• Atmus Filtration Techs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATMU#NYSE">ATMU</a>) is likely to report quarterly earnings at $0.59 per share on revenue of $421.40 million. 
• nVent Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVT#NYSE">NVT</a>) is expected to report quarterly earnings at $0.66 per share on revenue of $790.29 million. 
• Cinemark Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNK#NYSE">CNK</a>) is projected to report quarterly loss at $0.25 per share on revenue of $522.45 million. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is expected to report quarterly earnings at $0.38 per share on revenue of $295.59 million. 
• Xenia Hotels &amp; Resorts (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XHR#NYSE">XHR</a>) is likely to report quarterly earnings at $0.42 per share on revenue of $273.46 million. 
• AirSculpt Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRS#NASDAQ">AIRS</a>) is estimated to report quarterly loss at $0.03 per share on revenue of $39.25 million. 
• City Office REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIO#NYSE">CIO</a>) is expected to report quarterly earnings at $0.28 per share on revenue of $42.20 million. 
• Johnson Outdoors (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JOUT#NASDAQ">JOUT</a>) is expected to report quarterly earnings at $0.21 per share on revenue of $168.05 million. 
• AES (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AES#NYSE">AES</a>) is estimated to report quarterly earnings at $0.46 per share on revenue of $3.10 billion. 
• Patria Investments (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PAX#NASDAQ">PAX</a>) is projected to report quarterly earnings at $0.25 per share on revenue of $85.63 million. 
• Cboe Global Markets (BATS:<a class="ticker" href="https://www.benzinga.com/stock/CBOE#BATS">CBOE</a>) is likely to report quarterly earnings at $2.36 per share on revenue of $559.99 million. 
• T. Rowe Price Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TROW#NASDAQ">TROW</a>) is projected to report quarterly earnings at $2.13 per share on revenue of $1.78 billion. 
• Eaton Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ETN#NYSE">ETN</a>) is estimated to report quarterly earnings at $2.71 per share on revenue of $6.25 billion. 
• Apollo Global Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) is projected to report quarterly earnings at $1.96 per share on revenue of $4.64 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is projected to report quarterly earnings at $0.65 per share on revenue of $2.95 billion. 
• Chevron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVX#NYSE">CVX</a>) is likely to report quarterly earnings at $2.18 per share on revenue of $48.08 billion. 
• MISTRAS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MG#NYSE">MG</a>) is projected to report quarterly earnings at $0.90 per share on revenue of $9.68 billion. 
• ING Groep (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ING#NYSE">ING</a>) is estimated to report earnings for its first quarter. 
• Shell (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHEL#NYSE">SHEL</a>) is expected to report quarterly earnings at $1.65 per share on revenue of $79.13 billion. 
• IES Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IESC#NASDAQ">IESC</a>) is projected to report earnings for its second quarter. 
• Magna International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGA#NYSE">MGA</a>) is likely to report quarterly earnings at $0.86 per share on revenue of $9.73 billion. 
• Piper Sandler (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PIPR#NYSE">PIPR</a>) is likely to report quarterly earnings at $2.85 per share on revenue of $367.73 million. 
• Proto Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRLB#NYSE">PRLB</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $123.71 million. 
• Cigna Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) is estimated to report quarterly earnings at $6.35 per share on revenue of $60.39 billion. 
• BrightSpring Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTSG#NASDAQ">BTSG</a>) is estimated to report quarterly earnings at $0.09 per share on revenue of $2.74 billion. 
• Amneal Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRX#NASDAQ">AMRX</a>) is estimated to report quarterly earnings at $0.15 per share on revenue of $715.49 million. 
• DuPont de Nemours (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DD#NYSE">DD</a>) is projected to report quarterly earnings at $0.95 per share on revenue of $3.04 billion. 
• inTest (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/INTT#AMEX">INTT</a>) is likely to report quarterly loss at $0.10 per share on revenue of $28.07 million. 
• Butterfly Network (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BFLY#NYSE">BFLY</a>) is projected to report quarterly loss at $0.07 per share on revenue of $21.16 million. 
• Interface (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TILE#NASDAQ">TILE</a>) is estimated to report quarterly earnings at $0.21 per share on revenue of $297.11 million. 
• Vince Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VNCE#NYSE">VNCE</a>) is projected to report quarterly loss at $0.09 per share on revenue of $72.98 million. 
• NatWest Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NWG#NYSE">NWG</a>) is expected to report earnings for its first quarter. 
• AdvanSix (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASIX#NYSE">ASIX</a>) is projected to report quarterly earnings at $0.82 per share on revenue of $347.25 million. 
• Exxon Mobil (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XOM#NYSE">XOM</a>) is expected to report quarterly earnings at $1.70 per share on revenue of $86.09 billion. 
• Brookfield Business (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BBUC#NYSE">BBUC</a>) is estimated to report earnings for its first quarter. 
<h3>Companies Reporting After The Bell</h3>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AIRS

AMRX

ASIX

ATMU

BBUC

BEPC

BFLY

BTSG

CBOE

CRTO

FLGT

FUBO

IESC

INTT

JOUT

LBTYA

MSGS

PIPR

PRLB

PowerShares Exchange Traded Fund Trust Dynamic Mid Cap Value Portfolio

SHEL

TILE

TROW

VNCE

Earnings Scheduled For May 2, 2025

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is gearing up to announce its quarterly earnings on Friday, 2025-05-02. Here's a quick overview of what investors should know before the release.
Analysts are estimating that Westlake Chemical will report an earnings per share (EPS) of $0.35.
The market awaits Westlake Chemical's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
During the last quarter, the company reported an EPS beat by $0.06, leading to a 0.9% drop in the share price on the subsequent day.
Here's a look at Westlake Chemical's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.37</td>
<td>0.40</td>
<td>0.43</td>
<td>0.45</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.51</td>
<td>0.41</td>
<td>0.42</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746133286_0.png" alt="eps graph" />
<h3>Market Performance of Westlake Chemical's Stock</h3>
Shares of Westlake Chemical were trading at $23.39 as of April 30. Over the last 52-week period, shares are up 7.69%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/WLKP/earnings">To track all earnings releases for Westlake Chemical visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Uncovering Potential: Westlake Chemical's Earnings Preview

WIIM

Westlake Chemical Partners LP shares are trading higher after the company reported better-than-expected Q4 financial results.

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.43 per share which beat the analyst consensus estimate of $0.36 by 19.44 percent. This is a 4.88 percent increase over earnings of $0.41 per share from the same period last year. The company reported quarterly sales of $290.06 million which beat the analyst consensus estimate of $262.00 million by 10.71 percent. This is a 2.43 percent decrease over sales of $297.27 million the same period last year.

Earnings Beats

Westlake Chemical Q4 2024 GAAP EPS $0.43 Beats $0.36 Estimate, Sales $290.06M Beat $262.00M Estimate

<h3>Companies Reporting Before The Bell</h3>
• Kosmos Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) is expected to report quarterly earnings at $0.00 per share on revenue of $416.02 million. 
• Lincoln Educational Servs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINC#NASDAQ">LINC</a>) is estimated to report quarterly earnings at $0.29 per share on revenue of $110.85 million. 
• Summit Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) is projected to report earnings for its fourth quarter. 
• Clear Channel Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CCO#NYSE">CCO</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $645.84 million. 
• BioCryst Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BCRX#NASDAQ">BCRX</a>) is expected to report quarterly loss at $0.06 per share on revenue of $127.72 million. 
• Domino's Pizza (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NASDAQ">DPZ</a>) is expected to report quarterly earnings at $4.95 per share on revenue of $1.48 billion. 
• Gran Tierra Energy (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GTE#AMEX">GTE</a>) is projected to report earnings for its fourth quarter. 
• Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) is likely to report quarterly earnings at $0.37 per share on revenue of $1.08 billion. 
• Westlake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLK#NYSE">WLK</a>) is estimated to report quarterly earnings at $1.18 per share on revenue of $2.96 billion. 
• Owens-Corning (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OC#NYSE">OC</a>) is likely to report quarterly earnings at $2.90 per share on revenue of $2.77 billion. 
• Fresh Del Monte Produce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) is expected to report quarterly earnings at $0.37 per share on revenue of $1.03 billion. 
• Kaspi.kz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KSPI#NASDAQ">KSPI</a>) is estimated to report quarterly earnings at $3.35 per share on revenue of $1.52 billion. 
• Freightos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRGO#NASDAQ">CRGO</a>) is estimated to report quarterly loss at $0.09 per share on revenue of $6.46 million. 
• Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) is projected to report quarterly earnings at $0.10 per share on revenue of $1.01 billion. 
<h3>Companies Reporting After The Bell</h3>
• DMC Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BOOM#NASDAQ">BOOM</a>) is likely to report quarterly loss at $0.29 per share on revenue of $140.50 million. 
• Ultra Clean Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UCTT#NASDAQ">UCTT</a>) is estimated to report quarterly earnings at $0.44 per share on revenue of $559.19 million. 
• Clean Energy Fuels (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLNE#NASDAQ">CLNE</a>) is estimated to report quarterly loss at $0.01 per share on revenue of $99.87 million. 
• Goosehead Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSHD#NASDAQ">GSHD</a>) is likely to report quarterly earnings at $0.40 per share on revenue of $78.20 million. 
• Trex Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TREX#NYSE">TREX</a>) is likely to report quarterly earnings at $0.04 per share on revenue of $159.89 million. 
• Atlas Energy Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AESI#NYSE">AESI</a>) is likely to report quarterly earnings at $0.18 per share on revenue of $281.61 million. 
• Hims &amp; Hers Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HIMS#NYSE">HIMS</a>) is projected to report quarterly earnings at $0.21 per share on revenue of $469.68 million. 
• Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) is likely to report quarterly loss at $0.75 per share on revenue of $331.06 million. 
• Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $1.39 billion. 
• Faro Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) is estimated to report quarterly earnings at $0.40 per share on revenue of $91.03 million. 
• Riot Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) is likely to report quarterly loss at $0.27 per share on revenue of $130.25 million. 
• BWX Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) is likely to report quarterly earnings at $0.81 per share on revenue of $720.47 million. 
• SBA Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBAC#NASDAQ">SBAC</a>) is projected to report quarterly earnings at $2.22 per share on revenue of $684.39 million. 
• ONEOK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OKE#NYSE">OKE</a>) is estimated to report quarterly earnings at $1.55 per share on revenue of $6.77 billion. 
• Chegg (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CHGG#NYSE">CHGG</a>) is projected to report quarterly earnings at $0.18 per share on revenue of $142.03 million. 
• Artivion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>) is projected to report quarterly earnings at $0.04 per share on revenue of $101.15 million. 
• EverQuote (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EVER#NASDAQ">EVER</a>) is projected to report quarterly earnings at $0.39 per share on revenue of $133.83 million. 
• Cannae Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNNE#NYSE">CNNE</a>) is projected to report quarterly loss at $0.29 per share on revenue of $105.90 million. 
• Veracyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCYT#NASDAQ">VCYT</a>) is estimated to report quarterly earnings at $0.26 per share on revenue of $116.68 million. 
• Primoris Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRIM#NYSE">PRIM</a>) is estimated to report quarterly earnings at $0.76 per share on revenue of $1.59 billion. 
• Realty Income (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/O#NYSE">O</a>) is estimated to report quarterly earnings at $1.06 per share on revenue of $1.35 billion. 
• Trip.com Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TCOM#NASDAQ">TCOM</a>) is likely to report quarterly earnings at $0.54 per share on revenue of $1.69 billion. 
• HealthStream (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSTM#NASDAQ">HSTM</a>) is expected to report quarterly earnings at $0.14 per share on revenue of $73.55 million. 
• Myriad Genetics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) is estimated to report quarterly earnings at $0.03 per share on revenue of $213.34 million. 
• Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) is likely to report quarterly earnings at $0.29 per share on revenue of $326.77 million. 
• Topgolf Callaway Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MODG#NYSE">MODG</a>) is likely to report quarterly loss at $0.19 per share on revenue of $885.10 million. 
• Haverty Furniture Cos (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HVT#NYSE">HVT</a>) is likely to report quarterly earnings at $0.22 per share on revenue of $182.09 million. 
• JBT Marel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JBTM#NYSE">JBTM</a>) is estimated to report quarterly earnings at $1.85 per share on revenue of $488.74 million. 
• ProAssurance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PRA#NYSE">PRA</a>) is likely to report quarterly earnings at $0.19 per share on revenue of $274.56 million. 
• Inspirato (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ISPO#NASDAQ">ISPO</a>) is estimated to report quarterly loss at $1.09 per share on revenue of $58.34 million. 
• Quaker Houghton (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KWR#NYSE">KWR</a>) is projected to report quarterly earnings at $1.61 per share on revenue of $441.87 million. 
• Apartment Inv &amp; Mgmt (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AIV#NYSE">AIV</a>) is estimated to report quarterly loss at $0.12 per share on revenue of $53.10 million. 
• Navitas Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVTS#NASDAQ">NVTS</a>) is projected to report quarterly loss at $0.06 per share on revenue of $19.03 million. 
• Tempus AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEM#NASDAQ">TEM</a>) is projected to report quarterly loss at $0.15 per share on revenue of $200.55 million. 
• Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>) is expected to report quarterly earnings at $1.35 per share on revenue of $278.36 million. 
• Helios Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLIO#NYSE">HLIO</a>) is estimated to report quarterly earnings at $0.36 per share on revenue of $175.99 million. 
• Ziff Davis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZD#NASDAQ">ZD</a>) is likely to report quarterly earnings at $2.63 per share on revenue of $424.40 million. 
• Agora (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>) is estimated to report earnings for its fourth quarter. 
• Black Stone Minerals (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSM#NYSE">BSM</a>) is expected to report quarterly earnings at $0.33 per share on revenue of $114.99 million. 
• LTC Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LTC#NYSE">LTC</a>) is likely to report quarterly earnings at $0.65 per share on revenue of $42.81 million. 
• Zoom Communications (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) is projected to report quarterly earnings at $1.35 per share on revenue of $1.19 billion. 
• Douglas Dynamics (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLOW#NYSE">PLOW</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $155.23 million. 
• MediaAlpha (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MAX#NYSE">MAX</a>) is expected to report quarterly earnings at $0.39 per share on revenue of $289.38 million. 
• SI-BONE (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIBN#NASDAQ">SIBN</a>) is projected to report quarterly loss at $0.14 per share on revenue of $46.89 million. 
• Bridge Investment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRDG#NYSE">BRDG</a>) is expected to report quarterly earnings at $0.17 per share on revenue of $83.69 million. 
• Tortoise Capital Series Trust Tortoise Power and Energy Infrastructure Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPZ#NYSE">TPZ</a>) is expected to report earnings for its fourth quarter. 
• Offerpad Solutions (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OPAD#NYSE">OPAD</a>) is likely to report quarterly loss at $0.48 per share on revenue of $174.58 million. 
• Helix Energy Solns Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HLX#NYSE">HLX</a>) is likely to report quarterly earnings at $0.09 per share on revenue of $311.66 million. 
• Public Storage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSA#NYSE">PSA</a>) is projected to report quarterly earnings at $4.22 per share on revenue of $1.18 billion. 
• Clearway Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWEN#NYSE">CWEN</a>) is expected to report earnings for its fourth quarter. 
• V2X (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVX#NYSE">VVX</a>) is projected to report quarterly earnings at $1.15 per share on revenue of $1.10 billion. 
• Veris Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VRE#NYSE">VRE</a>) is expected to report quarterly earnings at $0.12 per share on revenue of $66.81 million. 
• GFL Environmental (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFL#NYSE">GFL</a>) is projected to report quarterly earnings at $0.23 per share on revenue of $1.98 billion. 
• Summit Hotel Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INN#NYSE">INN</a>) is projected to report quarterly earnings at $0.19 per share on revenue of $171.47 million. 
• Civitas Resources (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CIVI#NYSE">CIVI</a>) is estimated to report quarterly earnings at $1.88 per share on revenue of $1.29 billion. 
• Cleveland-Cliffs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLF#NYSE">CLF</a>) is expected to report quarterly loss at $0.44 per share on revenue of $4.54 billion. 
• Netstreit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NTST#NYSE">NTST</a>) is estimated to report quarterly earnings at $0.32 per share on revenue of $43.47 million. 
• KBR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBR#NYSE">KBR</a>) is estimated to report quarterly earnings at $0.82 per share on revenue of $2.00 billion. 
• Viper Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VNOM#NASDAQ">VNOM</a>) is projected to report quarterly earnings at $0.42 per share on revenue of $220.06 million. 
• Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) is likely to report quarterly earnings at $3.58 per share on revenue of $3.51 billion. 
• Apple Hospitality REIT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APLE#NYSE">APLE</a>) is likely to report quarterly earnings at $0.31 per share on revenue of $324.82 million. 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ADUS

AESI

AORT

APLE

AROC

AZUL

BCRX

BOOM

BRDG

BWXT

BYON

CHGG

CIVI

CLNE

CNNE

CRGO

CTRA

CWEN

EVER

FANG

FARO

GSHD

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HLIO

HSTM

ISPO

JBTM

KSPI

LINC

MODG

MYGN

NTST

NVTS

OPAD

PLOW

PRIM

RIOT

SBAC

SIBN

SMMT

TCOM

TREX

UCTT

VCYT

VNOM

Earnings Scheduled For February 24, 2025

In the current session, the stock is trading at $24.85, after a 3.54% increase. Over the past month, Westlake Chemical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) stock increased by 4.88%, and in the past year, by 5.63%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2024/1734111923_0.png" alt="Past Year Chart" />

<h3>Westlake Chemical P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 35.96 in the Chemicals industry, Westlake Chemical Inc. has a lower P/E ratio of 13.71. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1734111923_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

Markets

Price Over Earnings Overview: Westlake Chemical

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.36 by 41.67 percent. The company reported quarterly sales of $276.995 million which beat the analyst consensus estimate of $244.000 million by 13.52 percent. This is a 13.89 percent decrease over sales of $321.664 million the same period last year.

Westlake Chemical Q3 2024 GAAP EPS $0.51 Beats $0.36 Estimate, Sales $276.995M Beat $244.000M Estimate

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) will release its quarterly earnings report on Tuesday, 2024-11-05. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Westlake Chemical to report an earnings per share (EPS) of $0.37.
The announcement from Westlake Chemical is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Performance in Previous Earnings</h3>
Last quarter the company missed EPS by $0.02, which was followed by a 1.35% drop in the share price the next day.
Here's a look at Westlake Chemical's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.43</td>
<td>0.45</td>
<td>0.45</td>
<td>0.44</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.41</td>
<td>0.42</td>
<td>0.41</td>
<td>0.37</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.0%</td>
<td>2.0%</td>
<td>0.0%</td>
<td>-3.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1730743353_0.png" alt="eps graph" />
<h3>Tracking Westlake Chemical's Stock Performance</h3>
Shares of Westlake Chemical were trading at $22.35 as of November 01. Over the last 52-week period, shares are up 2.82%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<a href="https://www.benzinga.com/quote/WLKP/earnings">To track all earnings releases for Westlake Chemical visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Outlook For Westlake Chemical

In the current market session, Westlake Chemical Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) stock price is at $22.45, after a 0.04% drop. However, over the past month, the company's stock increased by 0.27%, and in the past year, by 4.76%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is not performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2024/1730122417_0.png" alt="Past Year Chart" />

<h3>Westlake Chemical P/E Compared to Competitors</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Compared to the aggregate P/E ratio of the 145.18 in the Chemicals industry, Westlake Chemical Inc. has a lower P/E ratio of 13.95. Shareholders might be inclined to think that the stock might perform worse than it's industry peers. It's also possible that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2024/1730122417_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

A Look Into Westlake Chemical Inc's Price Over Earnings

U.S. stock futures were mixed this morning, with the Dow futures gaining around 0.1% on Monday.
Shares of PDD Holdings Inc &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDD#NASDAQ">PDD</a>) fell sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/news/earnings/24/08/40548945/temu-parent-pdd-posts-86-q2-topline-growth-stock-drops-after-ceo-flags-upcoming-challenges">second-quarter revenue miss.</a>
PDD reported fiscal second-quarter 2024 revenue growth of 86% year-on-year to $13.36 billion (97.06 billion Chinese yuan), missing the analyst consensus estimate of $14.02 billion. The Chinese online retailer's adjusted earnings per ADS of $3.20 (23.24 Chinese yuan) increased from 10.47 Chinese yuan Y/Y, beating the analyst consensus estimate of $2.73.
PDD shares dipped 15.2% to $118.65 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>SM Energy Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SM#NYSE">SM</a>) fell 7.5% to $42.42 in pre-market trading after gaining over 3% on Friday.</li>
<li>Westlake Chemical Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) shares dipped 5.4% to $21.50 in pre-market trading.</li>
<li>AngioDynamics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANGO#NASDAQ">ANGO</a>) shares fell 5.1% to $7.29 in pre-market trading.</li>
<li>Daqo New Energy Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DQ#NYSE">DQ</a>) shares declined 5.1% to $14.43 in pre-market trading after reporting downbeat quarterly results.</li>
<li>Yiren Digital Ltd &#8211; ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) shares fell 4.6% to $4.63 in pre-market trading.</li>
<li>elf Beauty Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>) shares declined 3.8% to $164.50 in pre-market trading.</li>
<li>Guardant Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GH#NASDAQ">GH</a>) shares fell 3% to $28.20 in pre-market trading after gaining 4% on Friday.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40547904/pvh-likely-to-report-higher-q2-earnings-these-most-accurate-analysts-revise-forecasts-ahead-of-earn">PVH Likely To Report Higher Q2 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call</a></li>
</ul>

Pre-Market Outlook

Movers

ANGO

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session

A notable insider purchase on August 14, was reported by Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), based on the most recent SEC filing.
What Happened: In a recent Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024096710//Archives/edgar/data/1604665/000095017024096710/0000950170-24-096710-index.htm">U.S. Securities and Exchange Commission</a> on Wednesday, Kenner increased their investment in Westlake Chemical by purchasing 2,692 shares through open-market transactions, signaling confidence in the company's potential. The total transaction value is $60,914.
Westlake Chemical's shares are actively trading at $22.33, experiencing a down of 0.58% during Wednesday's morning session.
<h3>All You Need to Know About Westlake Chemical</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Westlake Chemical: Financial Performance Dissected</h3>
Positive Revenue Trend: Examining Westlake Chemical's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.57% as of 30 June, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Materials sector.
Insights into Profitability:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 35.62%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): With an EPS below industry norms, Westlake Chemical exhibits below-average bottom-line performance with a current EPS of 0.41.
</li>
</ul>
Debt Management: Westlake Chemical's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.45, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: Westlake Chemical's P/E ratio of 13.95 is below the industry average, suggesting the stock may be undervalued.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.67, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): The company's EV/EBITDA ratio 2.32 is below the industry average, indicating that it may be relatively undervalued compared to peers.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Unmasking the Significance of Insider Transactions</h3>
Considering insider transactions is valuable, but it's crucial to evaluate them in conjunction with other investment factors.
In legal terms, an "insider" refers to any officer, director, or beneficial owner of more than ten percent of a company's equity securities registered under Section 12 of the Securities Exchange Act of 1934. This can include executives in the c-suite and large hedge funds. These insiders are required to let the public know of their transactions via a Form 4 filing, which must be filed within two business days of the transaction.
When a company insider makes a new purchase, that is an indication that they expect the stock to rise.
Insider sells, on the other hand, can be made for a variety of reasons, and may not necessarily mean that the seller thinks the stock will go down. 
<h3>Deciphering Transaction Codes in Insider Filings</h3>
Delving into transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> typically prioritize those unfolding in the open market, as precisely outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Smart Money Move: Andrew Kenner Grabs $60K Worth Of Westlake Chemical Stock

Disclosed in the latest SEC filing, a significant insider purchase on August 12, involves Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>).
What Happened: In a significant move reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024095112//Archives/edgar/data/1604665/000095017024095112/0000950170-24-095112-index.htm">U.S. Securities and Exchange Commission</a> on Monday, Kenner purchased 12,000 shares of Westlake Chemical, demonstrating confidence in the company's growth potential. The total value of the transaction stands at $275,868.
Westlake Chemical's shares are actively trading at $22.61, experiencing a up of 0.62% during Monday's morning session.
<h3>Discovering Westlake Chemical: A Closer Look</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Financial Milestones: Westlake Chemical's Journey</h3>
Revenue Challenges: Westlake Chemical's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -0.18%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Navigating Financial Profits:
<ul>
<li>
Gross Margin: The company maintains a high gross margin of 35.62%, indicating strong cost management and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Westlake Chemical's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.41.
</li>
</ul>
Debt Management: The company faces challenges in debt management with a debt-to-equity ratio higher than the industry average. With a ratio of 1.45, caution is advised due to increased financial risk.
Insights into Valuation Metrics:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 14.25 is lower than the industry average, implying a discounted valuation for Westlake Chemical's stock.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.68, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): With a below-average EV/EBITDA ratio of 2.35, Westlake Chemical presents an opportunity for value investors. This lower valuation may attract investors seeking undervalued opportunities.
</li>
</ul>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Delving Into the Significance of Insider Transactions</h3>
Insider transactions shouldn't be used primarily to make an investing decision, however, they can be an important factor for an investor to consider.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
When dissecting transactions, the focal point for <a href="https://www.benzinga.com/money/investing-tools">investors</a> is often those occurring in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Eye On Growth: Andrew Kenner Adds $275K Of Westlake Chemical Stock To Portfolio

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.44 by 6.82 percent. This is a 20.59 percent increase over earnings of $0.34 per share from the same period last year. The company reported quarterly sales of $284.168 million which beat the analyst consensus estimate of $270.000 million by 5.25 percent. This is a 7.57 percent increase over sales of $264.177 million the same period last year.

Westlake Chemical Q2 2024 GAAP EPS $0.41 Misses $0.44 Estimate, Sales $284.168M Beat $270.000M Estimate

Management

Westlake Chemical Partners Appoints Jean-Marc Gilson As Director, President, And CEO; Albert Chao Transitions To Executive Chairman, James Chao To Senior Chairman; Gilson Previously CEO Of Mitsubishi Chemical Group Corporation; Appointments Effective Today

In a recent SEC filing, it was revealed that Andrew Kenner, SVP at Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>), made a noteworthy insider purchase on May 14,.
What Happened: Kenner made a significant move by purchasing 7,178 shares of Westlake Chemical as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0001604665/000095017024059168//Archives/edgar/data/1604665/000095017024059168/0000950170-24-059168-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $158,439.
As of Tuesday morning, Westlake Chemical shares are down by 0.0%, currently priced at $22.19.
<h3>Unveiling the Story Behind Westlake Chemical</h3>
Westlake Chemical Partners LP is a part of the chemical industry in the United States. Its operations are conducted through OpCo, it acquires and develop ethyelene production facilities, which convert ethane into ethylene. OpCo sells ethylene and its co-products such as propylene, crude butadiene, pyrolysis gasoline, and hydrogen to Westlake and other customers located in the United States. Its assets include three ethylene production facilities in Calvert City, Kentucky, and Lake Charles, Louisiana.
<h3>Key Indicators: Westlake Chemical's Financial Health</h3>
Revenue Growth: Westlake Chemical's revenue growth over a period of 3 months has faced challenges. As of 31 March, 2024, the company experienced a revenue decline of approximately -7.48%. This indicates a decrease in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Materials sector.
Key Profitability Indicators:
<ul>
<li>
Gross Margin: The company excels with a remarkable gross margin of 35.89%, indicating superior cost efficiency and profitability compared to its industry peers.
</li>
<li>
Earnings per Share (EPS): Westlake Chemical's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.42.
</li>
</ul>
Debt Management: With a high debt-to-equity ratio of 1.44, Westlake Chemical faces challenges in effectively managing its debt levels, indicating potential financial strain.
Evaluating Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: The P/E ratio of 14.41 is lower than the industry average, implying a discounted valuation for Westlake Chemical's stock.
</li>
<li>
Price to Sales (P/S) Ratio: The current P/S ratio of 0.67 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): Westlake Chemical's EV/EBITDA ratio, lower than industry averages at 2.39, indicates attractively priced shares.
</li>
</ul>
Market Capitalization: With restricted market capitalization, the company is positioned below industry averages. This reflects a smaller scale relative to peers.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Navigating the Impact of Insider Transactions on Investments</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
Within the legal framework, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities as per Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
The initiation of a new purchase by a company insider serves as a strong indication that they expect the stock to rise.
However, insider sells may not always signal a bearish view and can be influenced by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Digging into the details of stock transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0001604665">Check Out The Full List Of Westlake Chemical's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Westlake Chemical Recent Insider Activity

Westlake Chemical (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WLKP#NYSE">WLKP</a>) reported quarterly earnings of $0.42 per share which missed the analyst consensus estimate of $0.43 by 2.33 percent. The company reported quarterly sales of $284.673 million which beat the analyst consensus estimate of $281.000 million by 1.31 percent. This is a 7.48 percent decrease over sales of $307.677 million the same period last year.

Westlake Chemical Q1 2024 GAAP EPS $0.42 Misses $0.43 Estimate, Sales $284.673M Beat $281.000M Estimate

Although U.S. stocks closed mostly lower on Monday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#39;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/"> Benzinga&#39;s insider transactions </a> platform.
<h3>Sow Good </h3>
<ul>
<li>The Trade: Sow Good Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/sowg#OTC">SOWG</a>) Director Lyle Berman <a href="https://www.benzinga.com/quote/SOWG/analyst-ratings"> acquired a total of 68,966 shares </a> an average price of $7.25. To acquire these shares, it cost around $500,004.</li>
<li>What&rsquo;s Happening: On March 28, Sow Good announced a $3.7 million private placement.</li>
<li>What Sow Good Does: Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups.</li>
</ul>
<h3>Oncternal Therapeutics </h3>
<ul>
<li>The Trade: Oncternal Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/onct#NASDAQ">ONCT</a>) Director Robert James Wills acquired a total of 6,914 shares at an average price of $8.48. To acquire these shares, it cost around $58,602.</li>
<li>What&rsquo;s Happening: On March 7, Oncternal Therapeutics posted upbeat quarterly sales.</li>
<li>What Oncternal Therapeutics Does: Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need.</li>
</ul>
Don&rsquo;t forget to check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<h3>Westlake Chemical Partners </h3>
<ul>
<li>The Trade: Westlake Chemical Partners LP (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wlkp#NYSE">WLKP</a>) SVP, Olefin Material &amp; Corp Pr Andrew Kenner <a href="https://www.benzinga.com/sec/insider-trades/"> bought a total of 5,000 shares </a> at an average price of $22.23. To acquire these shares, it cost around $111,150.</li>
<li>What&rsquo;s Happening: On Feb. 20, Westlake Chemical posted downbeat quarterly results.</li>
<li>What Westlake Chemical Partners Does: Westlake Chemical Partners LP is a part of the chemical industry in the United States.</li>
</ul>
&nbsp;
Check This Out: <a href="https://www.benzinga.com/news/earnings/24/04/38038834/dave-busters-likely-to-report-higher-q4-earnings-here-are-the-recent-forecast-changes-from-wall-str"> Dave &amp; Buster&#39;s Likely To Report Higher Q4 Earnings; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts </a>

Long Ideas

Small Cap

ONCT

SOWG

Insiders Buying Westlake Chemical Partners And 2 Other Stocks

Press Releases

Westlake Chemical Partners Announce Third Quarter 2024 Earnings Conference Call

Westlake Chemical Partners LP Announces Third Quarter 2024 Distribution

Westlake Chemical Partners LP Announces Third Quarter 2024 Results

Westlake Chemical Partners LP Announces Fourth Quarter 2024 Distribution

Westlake Chemical Partners Announce Fourth Quarter and Full Year 2024 Earnings Conference Call

Westlake Chemical Partners LP Announces Fourth Quarter and Full Year 2024 Results

Comments

Westlake Chemical

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO